Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Family with sequence similarity 237 member A (FAM237A) is a small secreted peptide and protein, primarily expressed in the human brain, encoded by the FAM237A gene[2][5]. The canonical active form is a C-terminally amidated peptide containing 80 amino acids and a disulfide bond, required for its biological activity[1][4][6]. FAM237A functions as the endogenous agonist of the GPR83 receptor, binding with high affinity and specificity and activating signaling via the GNAQ pathway[3][4][6]. Multiple isoforms are predicted, but the physiologically relevant species is the amidated, processed form starting from residue 34, forming a ~9 kDa peptide[6]. FAM237A may play a role in neuropeptide signaling and central nervous system processes through GPR83 activation; however, its involvement in specific disease states or as a biomarker has not been demonstrated[3][6]. There are currently no reported drugs interacting with FAM237A, nor direct safety or therapeutic challenges described in the literature[5][6].
Endogenous agonist of GPR83 receptor (activates via GNAQ signaling pathway)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Family with sequence similarity 237 member A (FAM237A).